Osteoporosis, Best Practice & Research Compendium


Best Practice & Research Compendium

By Cyrus Cooper, MA, DM, FRCP, FMedSci, Director and Professor of Rheumatology, Southampton General Hospital, Southampton, UK; and Anthony D. Woolf, BSc, MBBS, FRCP, Professor of Rheumatology, Department of Rheumatology, Royal Cornwall Hospital, Truro, UK

Epidemiology of osteoporosis

Fractures in the elderly: epidemiology and demography

Pathogenesis of osteoporosis

Prenatal and childhood influences on osteoporosis

Corticosteroid osteoporosis

Lower peak bone mass and its decline

The role of bone turnover markers and risk factors
in the assessment of osteoporosis and fracture risk

The use of bone densitometry in clinical practice

Role of biochemical markers in the management of osteoporosis

Glucocorticoid-induced osteoporosis

Osteoporosis in men

Osteoporosis in childhood diseases: prevention and therapy

Post-menopausal osteoporosis

How to prevent fractures in the individual with osteoporosis

Non-pharmacological interventions


Oestrogen and selective receptor modulators
(SERMS): current roles in the prevention and treatment of osteoporosis

Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis

Biologic therapies in osteoporosis

Anabolic bone binding treatment [PTH] analogues and strontium

Cost utility of treatment of osteoporosis

Risk assessment in osteoporosis

Future methods in the assessment of bone mass and structure